PHASE-II TRIAL OF CARACEMIDE (NSC-253272) IN ADVANCED UNRESECTABLE NON-SMALL-CELL BRONCHOGENIC-CARCINOMA - AN ILLINOIS CANCER COUNCIL STUDY

被引：7
|
作者：
LAD, T
SCHOR, J
MULLANE, M
CARROLL, R
CHERNICOFF, D
BLOUGH, R
WEIDNER, L
机构：
[1] UNIV ILLINOIS,DEPT MED,MED ONCOL SECT,CHICAGO,IL 60680
[2] W SIDE VET AFFAIRS MED CTR,CHICAGO,IL
[3] CHICAGO OSTEOPATH MED CTR,CHICAGO,IL
来源：
INVESTIGATIONAL NEW DRUGS | 1992年 / 10卷 / 01期
关键词：
PHASE-II; CARACEMIDE; NON-SMALL-CELL LUNG CANCER;
D O I：
10.1007/BF01275475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [41] A PHASE-II TRIAL OF CARBOPLATIN AND VINDESINE IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER - A HELLENIC-COOPERATIVE-ONCOLOGY-GROUP STUDY
    PAVLIDIS, NA
    KLOUVAS, G
    NICOLAIDES, C
    KARANTANAS, A
    BEER, M
    FOUNTZILAS, G
    LUNG CANCER, 1993, 10 (1-2) : 85 - 89
  • [42] Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study
    Sakkaraiappan Ramalingam
    Tracy W. Dobbs
    Avi I. Einzig
    Slawomir Wojtowicz-Praga
    Marianne Cascino
    Phillip Bonomi
    Chandra P. Belani
    Cancer Chemotherapy and Pharmacology, 2004, 53 : 439 - 444
  • [43] Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer
    Krug, LM
    Miller, VA
    Kalemkerian, GP
    Kraut, MJ
    Ng, KK
    Heelan, RT
    Pizzo, BA
    Perez, W
    McClean, N
    Kris, MG
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 227 - 228
  • [44] A Phase II Study of the Docetaxel–Carboplatin Chemotherapy Regimen in Advanced Non-Small-Cell Lung Cancer
    Nicolas Tsavaris
    Christos Kosmas
    Elias Skopelitis
    Kostantinos Gennatas
    Alexandra Zorbala
    Paris Papas
    Panagiotis Gouveris
    George Antypas
    Sofia Rokana
    George Tzelepis
    Lung, 2005, 183 : 405 - 416
  • [45] Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study
    Ramalingam, S
    Dobbs, TW
    Einzig, AI
    Wojtowicz-Praga, S
    Cascino, M
    Bonomi, P
    Belani, CP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (05) : 439 - 444
  • [46] Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer
    Baldini, E
    Tibaldi, C
    Chella, A
    Angeletti, CA
    Silvano, G
    Andrei, A
    Algeri, R
    Conte, PF
    ANNALS OF ONCOLOGY, 1996, 7 (07) : 747 - 749
  • [47] Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer - A multicenter phase II study
    Santomaggio, C
    Tucci, E
    Rinaldini, M
    Algeri, R
    Righi, R
    Pepi, F
    Ghezzi, P
    Andrei, A
    Bellezza, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 67 - 71
  • [48] Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer
    Kim Y.H.
    Kim J.S.
    Choi Y.H.
    In K.H.
    Park H.S.
    Hong D.S.
    Jeong T.J.
    Lee Y.Y.
    Nam E.
    Lee S.N.
    Lee K.S.
    Kim H.K.
    International Journal of Clinical Oncology, 2002, 7 (2) : 114 - 119
  • [49] Clinical phase II trial of treosulfan in patients with non-resectable non-small-cell lung cancer
    von Pawel, J
    Gatzemeier, U
    Mehl, B
    Edler, L
    Baumgart, J
    Drings, P
    ONKOLOGIE, 1998, 21 (04): : 316 - 319
  • [50] PHASE-II STUDY OF CISPLATIN CONTINUOUS INFUSION PLUS VINDESINE IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER
    MORI, K
    SAITO, Y
    TOMINAGA, K
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (04): : 344 - 347
12345